NM_013363.4:c.193-12770C>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_013363.4(PCOLCE2):c.193-12770C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.57 in 152,026 control chromosomes in the GnomAD database, including 25,353 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.57 ( 25353 hom., cov: 32)
Consequence
PCOLCE2
NM_013363.4 intron
NM_013363.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.248
Publications
0 publications found
Genes affected
PCOLCE2 (HGNC:8739): (procollagen C-endopeptidase enhancer 2) Enables collagen binding activity; heparin binding activity; and peptidase activator activity. Predicted to be involved in positive regulation of peptidase activity. Predicted to act upstream of or within cellular response to leukemia inhibitory factor. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.636 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PCOLCE2 | ENST00000295992.8 | c.193-12770C>G | intron_variant | Intron 2 of 8 | 1 | NM_013363.4 | ENSP00000295992.3 | |||
| PCOLCE2 | ENST00000648195.1 | c.193-12770C>G | intron_variant | Intron 2 of 8 | ENSP00000497763.1 | |||||
| PCOLCE2 | ENST00000485766.1 | c.193-12770C>G | intron_variant | Intron 2 of 6 | 5 | ENSP00000419842.1 | ||||
| PCOLCE2 | ENST00000495732.5 | n.358-12770C>G | intron_variant | Intron 2 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.570 AC: 86616AN: 151908Hom.: 25324 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
86616
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.570 AC: 86696AN: 152026Hom.: 25353 Cov.: 32 AF XY: 0.566 AC XY: 42050AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
86696
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
42050
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
21030
AN:
41444
American (AMR)
AF:
AC:
7625
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2172
AN:
3470
East Asian (EAS)
AF:
AC:
1485
AN:
5164
South Asian (SAS)
AF:
AC:
1780
AN:
4824
European-Finnish (FIN)
AF:
AC:
7147
AN:
10574
Middle Eastern (MID)
AF:
AC:
150
AN:
290
European-Non Finnish (NFE)
AF:
AC:
43545
AN:
67964
Other (OTH)
AF:
AC:
1200
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1862
3724
5585
7447
9309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1347
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.